Dr Lim is based at Macquarie University Hospital and is researching immunotherapy for melanoma. She is determined to make a difference, specifically in finding ways to boost the human immune system to improve the effectiveness of current melanoma therapies.
What does the research entail? Esther is investigating inhibitors for a certain protein pathway in the body known as MAPK, which plays a key role in the development of melanoma. Work in the field has already improved survival rates of the 30% to 40% of Australian patients who have a form of the disease known as “BRAF-mutant” melanoma.